Phlow Recognizes National Essential Medicine Shortage Awareness Day 2023

2023, Corporate Statements

Together, We Will Protect America’s Medicine Cabinet and Solve Our Nation’s Drug Shortage Crisis Richmond, Virginia, September 8, 2023 – Phlow announced today that it will honor the 3rd National Essential Medicine Shortage Awareness Day (NEMSAD), a national observance...

Quality Up, Variability Down: Why the Switch to Continuous Processing

2023, Events, Recorded Events

The potential of continuous processing methodologies to reduce variability while increasing efficiency, productivity, and time-to-market are well proven in a range of industries—and has brought the same benefits to the pharmaceutical value chain. In this webinar,...

Phlow and OrbitalRX Improve Pharmaceutical Supply Chain Management within Hospital Pharmacies Through Strategic Partnership

2023, Corporate Statements

Phlow, a public benefit corporation on a mission to ensure a reliable supply of medicines essential for pediatric care, is proud to partner with OrbitalRX and its one-of-a-kind drug shortage management platform. OrbitalRX is designed by pharmacists, for pharmacists to...

Phlow Announces over $35M in Series B Funding to Improve the U.S. Medicine Supply Chain

2023, Press Releases

Phlow Corp., a U.S.-based public benefit corporation and contract development and manufacturing organization (CDMO), today announced that it has closed a $36 million Series B capital raise as part of its mission to protect America’s medicine cabinet. Since its launch...

Phlow Corp. Announces Formation of Business Advisory Board, New Board of Directors Appointment and Corporate President as Company Accelerates Towards Next Stage of Growth

2023, Press Releases

Addition of internationally recognized advisors, new board member, and President highlight Phlow’s commitment to create a reliable supply of affordable, high-quality essential medicines and deliver advanced manufacturing expertise to the pharmaceutical industry....